No Data
Barclays Maintains Marsh & McLennan(MMC.US) With Hold Rating, Raises Target Price to $246
Express News | Marsh & McLennan : Barclays Raises Target Price to $246 From $236
Employers Enhanced Health Benefits in 2024, Adding Coverage for Weight-Loss Medications and IVF Despite Growing Health Costs, Mercer Survey Finds
S&P Sees Some Signs of a US Credit Bubble as Spreads Tighten
RMA's Annual CRO Survey Reveals Cybersecurity, Fraud, and Rapid Response as Key Banking Risks in 2025
Press Release: Mercurius Media Capital Invests $1.5 Million in Captain Experiences to Expand Outdoor Adventures
No Data
No Data